No Data
No Data
Raycode (688800.SH): Not involved in the mobile consumer electronics sector.
Gelonghui on November 1st | Ruikeda (688800.SH) stated on the investor interaction platform that the company mainly serves in the new energy autos, energy storage, communication, siasun robot&automation, rail transit, and medical fields, without involvement in the consumer electronics sector.
Ruike Da (688800.SH): high-speed copper cable products solutions tailored for high-speed data transmission.
On October 31, Geelong reported that Recognada (688800.SH) stated on the investor interaction platform that the company has a high-speed copper cable product solution for transmitting high-speed data, and is currently in communication with some customers about the product solution.
Third Quarter Report 2024
Ricardo (688800.SH) released its performance for the first three quarters, with a net income of 0.106 billion yuan, a year-on-year increase of 10.6%.
Ricardo (688800.SH) disclosed the third quarter report for 2024, achieving revenue of 15....
Ruikeda (688800.SH): The net income in the first three quarters was 0.106 billion yuan, a year-on-year increase of 10.60%.
Geelong October 24th | Rikeda (688800.SH) announced that the company's revenue for the first three quarters was 1.589 billion yuan, a year-on-year increase of 52.75%; the net income attributable to shareholders of the listed company was 0.106 billion yuan, a year-on-year increase of 10.60%; the net profit attributable to shareholders of the listed company excluding non-recurring gains and losses was 99.8962 million yuan, a year-on-year increase of 15.54%; basic earnings per share were 0.67 yuan.
Raytech (688800.SH): Mainly serves in the fields of communication, new energy vehicles, energy storage, industrial robots, rail transportation, and medical.
Raythink (688800.SH) stated on the investor interaction platform on October 21st that the company's main services are in the fields of communication, new energy vehicles, energy storage, industrial robots, rail transportation, and medical.
No Data
No Data